Claria Medical is a pre-commercial medical device company focused on minimally invasive surgical tools for women’s health. Its lead product, the Claria System, is an investigational intelligent uterine containment and extraction system designed to improve laparoscopic hysterectomy for patients and physicians. The Claria System was selected for inclusion in the U.S. Food and Drug Administration’s Safer Technologies Program. Claria is continuing its clinical program and aims to obtain FDA clearance, with a pivotal clinical trial planned for 2023. The company has secured private financing and awards from the National Science Foundation and the National Institutes of Health to support development of products for hysterectomy, myomectomy and other procedures. Organon’s strategic investment is intended to support Claria’s ongoing development and potential commercialization efforts.

Total raised

$8M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2023